Trial signals major milestone in hunt for new TB drugs
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two ...
Jul 23, 2012
0
0